Loading...

BerGenBio ASA

BRRGFPNK
Healthcare
Biotechnology
$97.09
$0.00(0.00%)
U.S. Market opens in 0h 53m

BerGenBio ASA (BRRGF) Stock Competitors & Peer Comparison

See (BRRGF) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BRRGF$97.09+0.00%9.5B-0.48-$204.13N/A
NONOF$41.83+4.75%182.9B11.34$3.63+4.52%
CSLLY$23.07-0.36%91B15.26$1.54+3.10%
ARGNF$894.76+12.06%55.4B45.65$19.60N/A
UCBJF$285.29-2.10%54.3B30.32$9.41+0.55%
UCBJY$134.45-4.17%53.1B29.70$4.70+0.57%
CMXHF$90.49-1.35%45.1B15.06$6.17+3.14%
WXIBF$5.25+11.70%21.7B30.88$0.17N/A
IVBXF$11.45+11.27%19.7B163.57$0.07N/A
WXXWY$8.47-1.92%17.7B25.15$0.34N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BRRGF vs NONOF Comparison April 2026

BRRGF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BRRGF stands at 9.5B. In comparison, NONOF has a market cap of 182.9B. Regarding current trading prices, BRRGF is priced at $97.09, while NONOF trades at $41.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BRRGF currently has a P/E ratio of -0.48, whereas NONOF's P/E ratio is 11.34. In terms of profitability, BRRGF's ROE is -0.97%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, BRRGF is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for BRRGF.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions